{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T06:52:01Z","timestamp":1781247121321,"version":"3.54.1"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Hepatocyte transplantation (Hctx) is a potentially attractive method for the treatment of acute liver failure and liver-based metabolic disorders. Unfortunately, the procedure is hampered by the instant blood-mediated inflammatory reaction (IBMIR), a thromboinflammatory response elicited by the vascular innate immune system, causing activation of the coagulation and complement systems and clearance of transplanted cells. Observations have also revealed platelets adhered to the surface of the hepatocytes (Hc). To establish Hctx as a clinical treatment, all factors that trigger IBMIR need to be identified and controlled. This work explores the expression of von Willebrand factor (VWF) on isolated Hc resulting in tethering of platelets.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>VWF on Hc was studied by flow cytometry, confocal microscopy, immunoblot, and real-time polymerase chain reaction. Interaction between Hc and platelets was studied in a Chandler loop model. Adhesion of platelets to the hepatocyte surface was demonstrated by flow cytometry and confocal microscopy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>Isolated Hc constitutively express VWF on their cell surface and mRNA for VWF was found in the cells. Hc and platelets, independently of coagulation formed complexes, were shown by antibody blocking studies to be dependent on hepatocyte-associated VWF and platelet-bound glycoprotein Ib\u03b1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>VWF on isolated Hc causes, in contact with blood, adhesion of platelets, which thereby forms an ideal surface for coagulation. This phenomenon needs to be considered in hepatocyte-based reconstitution therapy and possibly even in other settings of cell transplantation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/tp.0000000000002707","type":"journal-article","created":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T23:14:08Z","timestamp":1553469248000},"page":"1630-1638","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Exposure of von Willebrand Factor on Isolated Hepatocytes Promotes Tethering of Platelets to the Cell Surface"],"prefix":"10.1097","volume":"103","author":[{"given":"Elisabet","family":"Gustafson","sequence":"first","affiliation":[{"name":"Department of Women\u2019s and Children\u2019s Health, Division of Pediatric Surgery, Uppsala University Hospital, Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama A.","family":"Hamad","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Deckmyn","sequence":"additional","affiliation":[{"name":"Laboratory for Thrombosis Research, IRF Life Sciences, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Barbu","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina N.","family":"Ekdahl","sequence":"additional","affiliation":[{"name":"Linn\u00e6us Center of Biomaterials Chemistry, Linn\u00e6us University, Kalmar, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Nilsson","sequence":"additional","affiliation":[{"name":"Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260309","doi-asserted-by":"crossref","first-page":"14.12.1","DOI":"10.1002\/0471140856.tx1412s62","article-title":"The history and use of human hepatocytes for the treatment of liver diseases: the first 100 patients.","volume":"62","author":"Hansel","year":"2014","journal-title":"Curr Protoc Toxicol"},{"key":"R2-20260309","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10545-017-0097-4","article-title":"Human heterologous liver cells transiently improve hyperammonemia and ureagenesis in individuals with severe urea cycle disorders.","volume":"41","author":"Meyburg","year":"2018","journal-title":"J Inherit Metab Dis"},{"key":"R3-20260309","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/hep.510290213","article-title":"Entry and integration of transplanted hepatocytes in rat liver plates occur by disruption of hepatic sinusoidal endothelium.","volume":"29","author":"Gupta","year":"1999","journal-title":"Hepatology"},{"key":"R4-20260309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3727\/096368911X566208","article-title":"Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in london.","volume":"21","author":"Puppi","year":"2012","journal-title":"Cell Transplant"},{"key":"R5-20260309","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/00007890-200209270-00020","article-title":"MHC-identical heart and hepatocyte allografts evoke opposite immune responses within the same host.","volume":"74","author":"Bumgardner","year":"2002","journal-title":"Transplantation"},{"key":"R6-20260309","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jhep.2016.12.017","article-title":"Host conditioning and rejection monitoring in hepatocyte transplantation in humans.","volume":"66","author":"Soltys","year":"2017","journal-title":"J Hepatol"},{"key":"R7-20260309","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/TP.0b013e31820ae459","article-title":"The instant blood-mediated inflammatory reaction characterized in hepatocyte transplantation.","volume":"91","author":"Gustafson","year":"2011","journal-title":"Transplantation"},{"key":"R8-20260309","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1053\/gast.2002.36592","article-title":"Kupffer cells participate in early clearance of syngeneic hepatocytes transplanted in the rat liver.","volume":"123","author":"Joseph","year":"2002","journal-title":"Gastroenterology"},{"key":"R9-20260309","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/diabetes.48.10.1907","article-title":"Incompatibility between human blood and isolated islets of langerhans: a finding with implications for clinical intraportal islet transplantation?","volume":"48","author":"Bennet","year":"1999","journal-title":"Diabetes"},{"key":"R10-20260309","doi-asserted-by":"crossref","first-page":"e21703","DOI":"10.1371\/journal.pone.0021703","article-title":"Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.","volume":"6","author":"Moll","year":"2011","journal-title":"PLOS One"},{"key":"R11-20260309","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1182\/blood-2012-09-455436","article-title":"Hepatocyte tissue factor activates the coagulation cascade in mice.","volume":"121","author":"Sullivan","year":"2013","journal-title":"Blood"},{"key":"R12-20260309","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/S0140-6736(02)12020-4","article-title":"Production of tissue factor by pancreatic islet cells as a trigger of detrimental thrombotic reactions in clinical islet transplantation.","volume":"360","author":"Moberg","year":"2002","journal-title":"Lancet"},{"key":"R13-20260309","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/stem.1111","article-title":"Are therapeutic human mesenchymal stromal cells compatible with human blood?","volume":"30","author":"Moll","year":"2012","journal-title":"Stem Cells"},{"key":"R14-20260309","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/29325","article-title":"A dual thrombin receptor system for platelet activation.","volume":"394","author":"Kahn","year":"1998","journal-title":"Nature"},{"key":"R15-20260309","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/0092-8674(91)90261-V","article-title":"Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation.","volume":"64","author":"Vu","year":"1991","journal-title":"Cell"},{"key":"R16-20260309","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1097\/01.TP.0000146386.77076.47","article-title":"Hepatocyte transplantation for inherited factor VII deficiency.","volume":"78","author":"Dhawan","year":"2004","journal-title":"Transplantation"},{"key":"R17-20260309","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molimm.2014.06.009","article-title":"The role and regulation of complement activation as part of the thromboinflammation elicited in cell therapies.","volume":"61","author":"Nilsson","year":"2014","journal-title":"Mol Immunol"},{"key":"R18-20260309","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.it.2009.09.005","article-title":"Can cells and biomaterials in therapeutic medicine be shielded from innate immune recognition?","volume":"31","author":"Nilsson","year":"2010","journal-title":"Trends Immunol"},{"key":"R19-20260309","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","article-title":"Of von willebrand factor and platelets.","volume":"72","author":"Bryckaert","year":"2015","journal-title":"Cell Mol Life Sci"},{"key":"R20-20260309","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1182\/blood-2008-10-165621","article-title":"Von willebrand factor to the rescue.","volume":"113","author":"De Meyer","year":"2009","journal-title":"Blood"},{"key":"R21-20260309","doi-asserted-by":"crossref","first-page":"21238","DOI":"10.1016\/S0021-9258(19)36916-9","article-title":"The interaction of the von willebrand factor-A1 domain with platelet glycoprotein ib\/IX. The role of glycosylation and disulfide bonding in a monomeric recombinant A1 domain protein.","volume":"268","author":"Cruz","year":"1993","journal-title":"J Biol Chem"},{"key":"R22-20260309","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1053\/euhj.2000.2515","article-title":"Platelet activation: assessment and quantification.","volume":"22","author":"Kamath","year":"2001","journal-title":"Eur Heart J"},{"key":"R23-20260309","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1055\/s-0038-1650400","article-title":"A3 domain is essential for interaction of von willebrand factor with collagen type III.","volume":"75","author":"Lankhof","year":"1996","journal-title":"Thromb Haemost"},{"key":"R24-20260309","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/S0090-9556(24)14951-3","article-title":"Drug metabolizing capacity of cryopreserved human, rat, and mouse liver parenchymal cells in suspension.","volume":"27","author":"Steinberg","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"R25-20260309","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1111\/j.1538-7836.2008.03034.x","article-title":"Complement activation triggered by chondroitin sulfate released by thrombin receptor-activated platelets.","volume":"6","author":"Hamad","year":"2008","journal-title":"J Thromb Haemost"},{"key":"R26-20260309","first-page":"494","article-title":"An examination of the fluid mechanics and thrombus formation time parameters in a chandler rotating loop system.","volume":"84","author":"Gardner","year":"1974","journal-title":"J Lab Clin Med"},{"key":"R27-20260309","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1160\/TH08-02-0073","article-title":"The humanized anti-glycoprotein ib monoclonal antibody h6b4-fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons.","volume":"100","author":"Fontayne","year":"2008","journal-title":"Thromb Haemost"},{"key":"R28-20260309","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1074\/jbc.M508191200","article-title":"Paratope determination of the antithrombotic antibody 82D6A3 based on the crystal structure of its complex with the von willebrand factor A3-domain.","volume":"281","author":"Staelens","year":"2006","journal-title":"J Biol Chem"},{"key":"R29-20260309","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/cyto.b.20026","article-title":"Fibrinogen receptor antagonists induce conformational changes of the human platelet glycoprotein iib.","volume":"62","author":"Seyfarth","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"R30-20260309","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.4049\/jimmunol.0902810","article-title":"Complement component C3 binds to activated normal platelets without preceding proteolytic activation and promotes binding to complement receptor 1.","volume":"184","author":"Hamad","year":"2010","journal-title":"J Immunol"},{"key":"R31-20260309","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/lt.21128","article-title":"Tissue factor-dependent procoagulant activity of isolated human hepatocytes: relevance to liver cell transplantation.","volume":"13","author":"St\u00e9phenne","year":"2007","journal-title":"Liver Transpl"},{"key":"R33-20260309","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1161\/ATVBAHA.113.301359","article-title":"Hypoxia results in upregulation and de novo activation of von willebrand factor expression in lung endothelial cells.","volume":"33","author":"Mojiri","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-20260309","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1111\/j.1742-4658.2006.05503.x","article-title":"Differential gene expression in periportal and perivenous mouse hepatocytes.","volume":"273","author":"Braeuning","year":"2006","journal-title":"Febs J"},{"key":"R35-20260309","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm.3770","article-title":"The ashwell-morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling.","volume":"21","author":"Grozovsky","year":"2015","journal-title":"Nat Med"},{"key":"R36-20260309","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5482\/HAMO-14-12-0081","article-title":"Interaction of von willebrand factor with platelets and the vessel wall.","volume":"35","author":"Ruggeri","year":"2015","journal-title":"Hamostaseologie"},{"key":"R37-20260309","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3727\/096368909X470775","article-title":"Liver cell transplantation: basic investigations for safe application in infants and small children.","volume":"18","author":"Meyburg","year":"2009","journal-title":"Cell Transplant"},{"key":"R38-20260309","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s10047-015-0834-0","article-title":"Proposal of a novel evaluation index for the effects of shear stress and exposure time on hepatocyte damage.","volume":"18","author":"Yasuda","year":"2015","journal-title":"J Artif Organs"},{"key":"R39-20260309","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1182\/blood-2006-06-028241","article-title":"Von willebrand factor and factor VIII are independently required to form stable occlusive thrombi in injured veins.","volume":"109","author":"Chauhan","year":"2007","journal-title":"Blood"},{"key":"R40-20260309","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s12272-012-1000-3","article-title":"Targeting von willebrand factor as a novel anti-platelet therapy; application of ARC1779, an anti-vwf aptamer, against thrombotic risk.","volume":"35","author":"Bae","year":"2012","journal-title":"Arch Pharm Res"},{"key":"R41-20260309","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/187152909787581327","article-title":"Von willebrand factor: drug and drug target.","volume":"9","author":"De Meyer","year":"2009","journal-title":"Cardiovasc Hematol Disord Drug Targets"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201908000-00020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T16:00:41Z","timestamp":1773072041000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201908000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002707","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]}}}